12 dead, 13 workers rescued as reactor blast rips through pharma unit near Hyderabad

Bodies of 12 workers were brought out and 13 others were rescued from under the debris after a blast in a reactor unit at Sigachi Industries Pvt. Ltd. in the Pashamylaram industrial area near Hyderabad on Monday (June 30, 2025) morning. The Fire Department officials said that all injured workers were rushed to nearby hospitals, with several of them suffering critical burn injuries. Fire Department officials said they are still searching for trapped personnel in the building debris of the collapsed unit.

On its website, the company Sigachi identifies itself as an industry leader in the field of pharma excipients, nutra and food ingredients. A listed entity, Sigachi Industries’ shares slumped in the wake of the incident. Around 2 pm, the shares were 13.61% lower, compared to the previous day’s closing price, at ₹47.67 apiece on the BSE.

A distress call was received by the Fire Control Room at 9.37 a.m., prompting the deployment of eleven fire tenders to the site.

The explosion reportedly took place in one of the reactors at the pharmaceutical manufacturing unit, triggering panic in the vicinity.

The firefighters are working to bring the blaze under control. Preliminary inquiries suggest that a pressure build-up in the reactor may have caused the blast.

A detailed investigation is underway to establish the exact cause and check whether safety protocols were being followed at the facility.

Related Posts

Lupin launches Ipratropium Bromide nasal spray in US

Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The Ipratropium Bromide nasal solution (nasal…

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

India’s largest drugmaker, Sun Pharmaceutical Industries Ltd., announced on Wednesday that its European biotech partner Philogen has voluntarily withdrawn the marketing authorisation application (MAA) for its investigational therapy Nidlegy from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr